전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
informazzjoni limitata dwar sustanzi oħrajn tal-kuntrast ta’ gadolinium tissuġġerixxi li għall- esklużjoni ta’ metastasi kranjali addizzjonali f’pazjent b’metastasi solitarja magħrufa li tista’ tinqata’, eżami ta’ mr b’injezzjoni tad-doża ta’ 300 mikromol/kg ta’ piż tal-ġisem ta’ optimark, jista’ jwassal għal kunfidenza dijanjostika ogħla.
limited data with other gadolinium contrast agents suggests that for the exclusion of additional cranial metastases in a patient with a known solitary resectable metastasis, an mr exam with the injection of the dose of 300 micromol/kg body weight of optimark may lead to higher diagnostic confidence.